163 related articles for article (PubMed ID: 15047782)
1. The content and comprehensiveness of hepatitis C education in methadone maintenance and drug-free treatment units.
Strauss SM; Astone JM; Hagan H; Des Jarlais DC
J Urban Health; 2004 Mar; 81(1):38-47. PubMed ID: 15047782
[TBL] [Abstract][Full Text] [Related]
2. Gaps in the drug-free and methadone treatment program response to Hepatitis C.
Strauss SM; Astone J; Vassilev ZP; Des Jarlais DC; Hagan H
J Subst Abuse Treat; 2003 Jun; 24(4):291-7. PubMed ID: 12867202
[TBL] [Abstract][Full Text] [Related]
3. Provision of hepatitis C education in a nationwide sample of drug treatment programs.
Astone J; Strauss SM; Vassilev ZP; Des Jarlais DC
J Drug Educ; 2003; 33(1):107-17. PubMed ID: 12773028
[TBL] [Abstract][Full Text] [Related]
4. Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.
Novick DM; Kreek MJ
Addiction; 2008 Jun; 103(6):905-18. PubMed ID: 18422827
[TBL] [Abstract][Full Text] [Related]
5. A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United States.
Strauss SM; Astone JM; Jarlais DD; Hagan H
Drug Alcohol Depend; 2004 Mar; 73(3):227-36. PubMed ID: 15036545
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia.
Mukherjee TI; Pillai V; Ali SH; Altice FL; Kamarulzaman A; Wickersham JA
Int J Drug Policy; 2017 Sep; 47():144-152. PubMed ID: 28652072
[TBL] [Abstract][Full Text] [Related]
7. Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.
Vassilev ZP; Strauss SM; Astone J; Des Jarlais DC
J Behav Health Serv Res; 2004; 31(2):208-16. PubMed ID: 15255228
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of HIV, HCV and tuberculosis and associated risk behaviours among new entrants of methadone maintenance treatment clinics in Guangdong Province, China.
Zhang L; Zhang D; Chen W; Zou X; Ling L
PLoS One; 2013; 8(10):e76931. PubMed ID: 24116185
[TBL] [Abstract][Full Text] [Related]
9. Missed opportunities for hepatitis C testing in opioid treatment programs.
Frimpong JA
Am J Public Health; 2013 Jun; 103(6):1028-30. PubMed ID: 23597374
[TBL] [Abstract][Full Text] [Related]
10. Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
Astone JM; Strauss SM; Hagan H; Des Jarlais DC
Am J Drug Alcohol Abuse; 2004 Nov; 30(4):783-97. PubMed ID: 15624549
[TBL] [Abstract][Full Text] [Related]
11. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
12. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
[TBL] [Abstract][Full Text] [Related]
13. Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.
Strauss SM; Astone-Twerell J; Munoz-Plaza CE; Des Jarlais DC; Gwadz M; Hagan H; Osborne A; Rosenblum A
BMC Health Serv Res; 2007 Mar; 7():39. PubMed ID: 17346346
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with HIV/HCV infection among entrants in methadone maintenance treatment clinics in China: a systematic review and meta-analysis.
Zhuang X; Wang Y; Chow EP; Liang Y; Wilson DP; Zhang L
Drug Alcohol Depend; 2012 Dec; 126(3):286-95. PubMed ID: 22726912
[TBL] [Abstract][Full Text] [Related]
15. A nationwide survey of hepatitis C services provided by drug treatment programs.
Strauss SM; Falkin GP; Vassilev Z; Des Jarlais DC; Astone J
J Subst Abuse Treat; 2002 Mar; 22(2):55-62. PubMed ID: 11932130
[TBL] [Abstract][Full Text] [Related]
16. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.
Ng MH; Chou JY; Chang TJ; Lee PC; Shao WC; Lin TY; Chen VC; Gossop M
Addict Behav; 2013 Apr; 38(4):2089-93. PubMed ID: 23403277
[TBL] [Abstract][Full Text] [Related]
17. Methadone maintenance and hepatitis C virus infection among injecting drug users.
Crofts N; Nigro L; Oman K; Stevenson E; Sherman J
Addiction; 1997 Aug; 92(8):999-1005. PubMed ID: 9376782
[TBL] [Abstract][Full Text] [Related]
18. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-related knowledge and willingness to receive treatment among patients on methadone maintenance.
Zeremski M; Dimova RB; Zavala R; Kritz S; Lin M; Smith BD; Zibbell JE; Talal AH
J Addict Med; 2014; 8(4):249-57. PubMed ID: 24820257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
